Interventions for Ear Infections
(DISAPEAR Trial)
Trial Summary
What is the purpose of this trial?
This study aims to improve care and reduce unnecessary antibiotic prescribing for children with ear infections. The study will compare the effectiveness of a "gold standard" to a hybrid intervention combined with this gold standard, in order to identify steps to increase parent satisfaction for child ear infection care. The "gold standard" approach is a Health System Level Intervention. On its own, it involves clinician education, tools in electronic medical records, and audit and feedback reports for clinician prescribing habits. The hybrid intervention includes the elements of the health systems level intervention in addition to a Shared Decision-Making component, which allows for both an increase in the role parents play in their child's care, as well as clinician education for how to use this method. The goals of this work are to increase parent satisfaction, reduce antibiotics taken for childhood ear infections, align medical care with the current national guidelines, and evaluate differences in the two intervention groups. Both groups will be evaluated for implementation outcomes to improve dissemination and scalability for future use of these models in antibiotic prescribing for children with ear infections. This study will recruit a diverse group of patients and clinicians to complete surveys, parents to participate in focus groups, and clinicians and administrators to be interviewed in order to meet study aims and receive sufficient feedback on the interventions performed. There are two hypotheses for this research: 1. The Hybrid Intervention will have higher parent satisfaction and reduced antibiotic use compared to the Health-System Level Intervention and 2. The Hybrid Intervention will be more challenging to implement than the Health-System Level Intervention, but will be preferred by parents, clinicians, and administrators.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It focuses on interventions for ear infections and does not mention any medication restrictions.
What data supports the effectiveness of the treatment Shared decision-making (SDM) education and Use of a shared decision-making (SDM) aide for ear infections?
Research shows that shared decision-making (SDM) can improve patient satisfaction and outcomes by involving patients and families in treatment decisions, which is beneficial in managing conditions like ear infections. Studies indicate that SDM can reduce the unnecessary use of antibiotics in children with ear infections, leading to better disease management.12345
Is shared decision-making (SDM) safe for use in clinical settings?
How is the shared decision-making treatment for ear infections different from other treatments?
The shared decision-making (SDM) treatment for ear infections is unique because it involves patients, families, and clinicians working together to choose the best treatment plan, rather than just following a doctor's orders. This approach can improve patient satisfaction and outcomes by considering multiple treatment options and reducing the unnecessary use of antibiotics.12346
Research Team
Holly Frost, MD
Principal Investigator
Intermountain Health
Eligibility Criteria
This trial is for children aged 6 months to 17 years with ear infections, and their parents or guardians who are at least 18. Clinicians treating these conditions can also participate. Participants must be part of a clinic that agrees to implement the study interventions.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention Implementation
Implementation of the Health System Level and Hybrid Interventions at clinic sites, including clinician education and shared decision-making components
Evaluation
Evaluation of intervention outcomes using surveys, focus groups, and interviews to assess parent satisfaction and antibiotic use
Follow-up
Participants are monitored for adverse drug events and other outcomes post-intervention
Treatment Details
Interventions
- Shared decision-making (SDM) education (Behavioural Intervention)
- Use of a shared decision-making (SDM) aide (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Denver Health and Hospital Authority
Lead Sponsor
AllianceChicago
Collaborator
Patient-Centered Outcomes Research Institute
Collaborator
Nakela L. Cook
Patient-Centered Outcomes Research Institute
Chief Executive Officer since 2020
MD, MPH
Harv Feldman
Patient-Centered Outcomes Research Institute
Chief Medical Officer
MD, MSCE
Intermountain Health Care, Inc.
Collaborator
Mayo Clinic
Collaborator
Dr. Gianrico Farrugia
Mayo Clinic
Chief Executive Officer since 2019
MD from University of Malta Medical School
Dr. Richard Afable
Mayo Clinic
Chief Medical Officer
MD from Loyola Stritch School of Medicine